![SHANGHAI, CHINA - JANUARY 6, 2023 - Azvudine tablets in Shanghai, China, January 6, 2022. Azvudine tablet is an oral small-molecule COVID-19 treatment drug independently developed in China, which can be used SHANGHAI, CHINA - JANUARY 6, 2023 - Azvudine tablets in Shanghai, China, January 6, 2022. Azvudine tablet is an oral small-molecule COVID-19 treatment drug independently developed in China, which can be used](https://c8.alamy.com/comp/2M72CT7/shanghai-china-january-6-2023-azvudine-tablets-in-shanghai-china-january-6-2022-azvudine-tablet-is-an-oral-small-molecule-covid-19-treatment-drug-independently-developed-in-china-which-can-be-used-to-treat-adult-patients-with-common-novel-coronavirus-pneumonia-photo-by-cfotosipa-usa-2M72CT7.jpg)
SHANGHAI, CHINA - JANUARY 6, 2023 - Azvudine tablets in Shanghai, China, January 6, 2022. Azvudine tablet is an oral small-molecule COVID-19 treatment drug independently developed in China, which can be used
![Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients | Signal Transduction and Targeted Therapy Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients | Signal Transduction and Targeted Therapy](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41392-021-00835-6/MediaObjects/41392_2021_835_Fig1_HTML.png)
Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients | Signal Transduction and Targeted Therapy
![SHANGHAI, CHINA - JANUARY 6, 2023 - Azvudine tablets in Shanghai, China, January 6, 2022. Azvudine tablet is an oral small-molecule COVID-19 treatment Stock Photo - Alamy SHANGHAI, CHINA - JANUARY 6, 2023 - Azvudine tablets in Shanghai, China, January 6, 2022. Azvudine tablet is an oral small-molecule COVID-19 treatment Stock Photo - Alamy](https://c8.alamy.com/comp/2M72CEN/shanghai-china-january-6-2023-azvudine-tablets-in-shanghai-china-january-6-2022-azvudine-tablet-is-an-oral-small-molecule-covid-19-treatment-2M72CEN.jpg)
SHANGHAI, CHINA - JANUARY 6, 2023 - Azvudine tablets in Shanghai, China, January 6, 2022. Azvudine tablet is an oral small-molecule COVID-19 treatment Stock Photo - Alamy
![A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study - Ren - 2020 - Advanced Science - Wiley Online Library A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study - Ren - 2020 - Advanced Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/738e09ff-412a-4649-adbc-c8ef9625db20/advs1963-gra-0001-m.jpg?trick=1682904179993)
A Randomized, Open‐Label, Controlled Clinical Trial of Azvudine Tablets in the Treatment of Mild and Common COVID‐19, a Pilot Study - Ren - 2020 - Advanced Science - Wiley Online Library
![Azvudine (FNC): a promising clinical candidate for COVID-19 treatment | Signal Transduction and Targeted Therapy Azvudine (FNC): a promising clinical candidate for COVID-19 treatment | Signal Transduction and Targeted Therapy](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41392-020-00351-z/MediaObjects/41392_2020_351_Fig1_HTML.png)
Azvudine (FNC): a promising clinical candidate for COVID-19 treatment | Signal Transduction and Targeted Therapy
![Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic_News_News_FOSUN Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic_News_News_FOSUN](https://en.fosun.com/Upload/image/20230201/20230201174844_8151.png)
Delivery of 170,000 Bottles of Azvudine Tablets During Spring Festival to Help Rural Areas Weather the Epidemic_News_News_FOSUN
![Vaccines | Free Full-Text | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19 Vaccines | Free Full-Text | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19](https://www.mdpi.com/vaccines/vaccines-11-00332/article_deploy/html/images/vaccines-11-00332-g006.png)
Vaccines | Free Full-Text | A Clinical Insight on New Discovered Molecules and Repurposed Drugs for the Treatment of COVID-19
People's Daily, China on Twitter: "Azvudine, China's first domestically developed oral drug for #COVID19 treatment, has set its initial price at less than 300 yuan ($44.4) per bottle, which contains 35 tablets,
![China's first domestic oral anti-COVID-19 drug is priced at less than 300 yuan per bottle/35 tablets - Global Times China's first domestic oral anti-COVID-19 drug is priced at less than 300 yuan per bottle/35 tablets - Global Times](https://www.globaltimes.cn/Portals/0/attachment/2021/2021-11-24/31d9a71d-4196-4b80-b98a-4dd45ebf5255.jpeg)